USP22 and cancer: To further validate the specificity of the upregulation, we made siRNA-mediated USP7-knockdown (USP7-Kd) in A549 and H1299 lung cancer cells and found that USP7-Kd also markedly upregulates USP22 (Fig. 1D) in both cancer cell lines.